混合术式髂股动脉内膜剥脱术治疗严重广泛闭塞病变的长期结局
单中心回顾性分析125例混合式逆行髂股动脉内膜剥脱术,平均随访29个月,主要截肢免除率98%,末次随访一期通畅率90%,ABI与趾压均显著改善,提示该术式对严重髂股闭塞病变安全有效且长期通畅良好。
要点
- 混合式逆行髂股动脉内膜剥脱术5年以上随访显示良好一期通畅率与截肢免除率。
- 术后ABI与趾压显著改善,支持其血流动力学获益。
核心结论
- 混合式逆行髂股动脉内膜剥脱术是治疗严重髂股闭塞病变安全有效的选择,提供优异长期一期通畅率和ABI改善。
研究设计与样本
- 单中心回顾性研究,纳入2010年1月1日至2022年11月1日125例混合式逆行髂股动脉内膜剥脱术。
主要发现
- 平均随访29±32个月(范围0-125个月),主要截肢免除率98%,末次随访一期通畅率90%。
- ABI从0.43±0.19改善至0.74±0.23(P<0.01),趾压从32±23 mm Hg改善至65±32 mm Hg(P<0.01)。
临床怎么用
- 在股动脉内膜剥脱联合髂外/总动脉重建时,可考虑该混合术式以实现微创且持久的长期通畅。
局限性
- 单中心回顾性设计可能限制结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Iliofemoral peripheral arterial disease is contemporarily managed via endovascular approaches and groin cutdown, given the morbidity associated with open surgical reconstructions. However, endovascular reconstruction is afflicted with high rates of restenosis. Our group has previously shown that hybrid-based retrograde iliofemoral endarterectomy is safe, efficacious, and yields excellent outcomes at 1-2 years. This study aims to show ongoing outcomes at 5 years or greater. METHODS: This study is a single-institution, retrospective review of 125 hybrid-based, retrograde iliofemoral endarterectomies from January 1, 2010, to November 1, 2022. Data collected from electronic medical records were analyzed using standard quantitative statistical techniques. The primary outcomes were mortality and freedom from major amputation. The secondary outcomes included patency rates and changes in ankle-brachial index (ABI) and toe pressures. RESULTS: A total of 125 limbs in 111 patients were included in this study. Fifty-seven percent of patients presented with critical limb ischemia. Ninety-seven percent of patients had TransAtlantic Inter-Society Consensus II C or D lesions. The average length of follow-up was 29 ± 32 months (range 0-125 months). Freedom from major amputation was 98%, and the primary patency rate was 90% at last follow-up. ABIs improved from 0.43 ± 0.19 to 0.74 ± 0.23 (P < 0.01), and toe pressures improved from 32 ± 23 mm Hg to 65 ± 32 mm Hg (P < 0.01). CONCLUSION: Hybrid-based, retrograde iliofemoral endarterectomy is a safe and efficacious treatment option for patients with severe iliofemoral occlusive disease. It provides excellent long-term primary patency and improvement in ABI. This technique should be considered during femoral endarterectomy with external/common iliac reconstruction as a means of achieving minimally invasive, durable, long-term patency.
引用
- Napier JA, Kato PJ, Sundararaghavan V, et al. Long-Term Outcomes of Hybrid-Based Iliofemoral Endarterectomy for Severe, Extensive Occlusive Disease. Ann Vasc Surg. 2025. PMID: 40582461. doi:10.1016/j.avsg.2025.06.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。